WNT Signaling Pathway and Stem Cell Signaling Network
By Masuko Katoh, M. Katoh. Clinical Cancer Research, 2007
762 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/3c1735087d39466ee251f85e7a1bfe7107aa621d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- N. Vey
- V. Gelsi-Boyer
- M. Mozziconacci
- S. Olschwang
- L. Xerri
- T. Prebet
- J. Adélaïde
- Julien Bonansea
Citations in the corpus
- Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia (2009, background): “…deletions of CXXC4, DVL2, LRP5L and gain of MAP3K4 (Fig 1), which all encode regulators of the WNT pathway (Gong et al, 2001; Hino et al, 2001; Wong et al, 2004; Katoh & Katoh, 2007; Kojima et al, 2009), suggest that the WNT pathway (canonical and/or non-canonical) may be altered in MDS (Fig S1).”